CL vs VXRT · P/E 34, rev $20.38B vs rev $28.7M
Colgate-Palmolive Company (CL) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the CL and VXRT stock pages for the full models.
Not investment advice.